Home › ADVANCED MEDICAL ASSOCIATES, LLC › Areza Medical

Areza Medical

ADVANCED MEDICAL ASSOCIATES, LLC · Model SA425100 · UDI-DI 00850021481810

FRO

510(k) clearances

3,166

Adverse events (64 deaths)

Recalls

383

Facilities

Description

The dressing is made from natural alginate fibers and silver. Silver particle in the dressing can restrain growth of biologic pathogens in the wound and help reduce further wound infection. The dressing has been tested in vitro and found to be effective against several important biologic pathogens affecting wounds. It is designed to be highly absorbent. The dressing, while absorbing wound drainage (exudates), forms a gel-like covering over the wound, which provides an ideal moist environment. Moist wound healing is known to expedite wound healing. The gel-like surface also prevents the dressing from adhering to the wound, making removal painless.

Recalls

Date	Firm	Reason
2026-06-08	ConvaTec, Inc	Surgical dressing manufactured out of specification (greater thickness).
2026-04-27	Oculus Technologies of Mexico, S.A. de C.V.	The recall is being conducted due to corrosion of the internal metallic spring within the sprayer component. This condition is caused by material incompatibility between the produc
2026-01-16	Integra LifeSciences Corp. (NeuroSciences)	Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16	Integra LifeSciences Corp. (NeuroSciences)	Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16	Integra LifeSciences Corp. (NeuroSciences)	Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-05	Medline Industries, LP	Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2026-01-05	Medline Industries, LP	Medline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2025-08-05	Integra LifeSciences Corp. (NeuroSciences)	Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05	Integra LifeSciences Corp. (NeuroSciences)	Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05	Integra LifeSciences Corp. (NeuroSciences)	Packaging failures were identified which could lead to a breach in the sterile barrier.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.